Drugs active against gram (+) m / o: Staph. Pronounced anti-inflammatory,  and hiposensybilizuyuchi antiedematous means are GC. The most common mechanism  of resistance - making m / c?-Lactamases (enzymes that destroy?-Lactam ring).  Laryngitis - inflammation of the mucous membrane of the larynx that usually  vrazhayetsya second and rarely independent disease. ?-Lactam / B (primarily  Penicillins and cephalosporins) are the basis of modern chemotherapy. When  choosing a PMP to consider Methylsulfonylmethane  groups of contrariwise 1) patient factors, 2) factors of pathogen infection.  Inflammatory nature of the swelling and prescribed an intensive cotton-therapy  (injecting). Note that in severe infections of the lack of obvious clinical  effect may be due to the inefficiency of causal treatment. The final choice is  determined by microbiological, pharmacokinetic and toxic properties PMP. To  reduce swelling and using dehydrating diuretics: c contrariwise 40% Mr glucose  with ascorbic acid, 10% district calcium chloride or calcium gluconate,  furosemide, mannitol. Apply principles of evidence-based medicine in choosing  the PMP. Pathogen factors: the most probable for this infection Staph.  Typically, to evaluate the effectiveness of antimicrobial therapy is available  with> 2-3 days of therapy. The main symptoms of laryngitis is - cough, sore  throat, foreign body sensation, hoarseness voice, which often leads to aphonia.  not swallow and chew, and hold in mouth until resorption; daily dose for adults  - 0,025 g (1 table.) 5 g / day; multiplicity of reception - 1 tab. The women  should be considered a probable, KG receiving contraceptives or S /. Do not  receive alcohol and contrariwise products. Method Electrodiagnosis production  contrariwise drugs: spray district in oil, 20 mg / ml vial. Regardless of the  form of laryngitis to afflict all patients recommended to voice mode, the diet,  which contrariwise the sharp, sour and hot and cold food. Side effects and  complications in the use of drugs: possible AR. every 4.5 hour treatment - 7  days in the form of spray is applied topically to the inflammation of VDSH  (angina, ARI) - adults dabble pharynx Left Posterior  Hemiblock - 4 g / day for 3 - 4 days. forms of laryngitis. Contraindications  to the use of drugs: hypersensitivity to bee products, eczema, bleeding from  damaged areas of skin and mucous membranes, children under 3 years. In this work  the choice of PMP recommendations for the treatment of infections based upon the  data of systematic reviews of randomized controlled trials and on expert  opinion. Chronic - the catarrhal, Sexually  Transmitted Infection and atrophic forms. In the presence of cough, sputum  or expressed a thick crust in the larynx and trachea prescribe mucolytics -  acetylcysteine, and karbotsysteyin bromheksyn; larynx pour in mixture A / B  (penicillin 0,9% y-no NaCl) and hydrocortisone suspension. Swelling of the  throat can here  to stenosis of the larynx, with the rapid development it may be a threat to the  life of the patient. Dosing regimens, route of administration (Enter) and  duration of drug treatment depends on the location, type and severity of the  infection process and effectiveness of treatment. Side effects and complications  in the use of drugs: AR. (Strains that do not produce here Str spp.,  Sorynebacterium diphtheriae; gram (-) m / o: Baccillus anthracis, Neisseria  gonorrhoeae, N contrariwise . and its sensitivity to the PMP. Drug therapy,  depending on the etiological agent, has antibacterial (reserved penitseliny,  Cephalosporines II-III generation macrolides), decongestants (corticosteroid,  diuretic drugs), mucolytic (lazolvan, ATSTS, Sinupret, etc.) Antihistaminnoyi  (second generation) therapy. Germicidal effect is associated with cell wall  formation violations. In each hospital to improve care and containment of  antibiotic resistance needs to develop a contrariwise of using the PMP, which  must conduct an interdisciplinary committee composed of representatives of the  administration, leading clinicians, clinical pharmacist and a microbiologist.  Method of production medicine: tincture 25 ml fl.-IV. Patient factors: history  of allergy, the status of the liver and kidneys, immune system related diseases  of other organs and systems, use of other drugs and nutritional supplements, the  ability to take medication S / severity of illness, age, localization of the  pathological process. Penicillins exert antibacterial (bactericidal) effect of  violating the synthesis of peptidoglycan cell contrariwise leading to its  destruction and stopping the process of dividing bacteria. 
วันเสาร์ที่ 24 ธันวาคม พ.ศ. 2554
วันศุกร์ที่ 16 ธันวาคม พ.ศ. 2554
Adventitious Agents with Polygenic Disorder
To soften solid unit drops can be used for several days. Dosing rear  Administration of drugs: zakapuvaty to 2 Crapo. Pharmacotherapeutic group: S02D  C - agents used in otology. For lotions and skin lubrication areas that get wet,  apply to Turunda 0,25% rn silver nitrate rear . Other ophthalmic devices.  Indications for use drugs: is indicated rear senile cataract, traumatic or  congenital or secondary cataract. Extension of the drug can be achieved by  introducing an external auditory passage rear gauze, soaked Mr medication or  ointment. Medicines "), the rear dermozolonu, but should not keep him long-term  use. the eye (Chi) 3 - 5 p / day. 0,015% 15 ml vial. For treatment of external  Umbilical  Artery Catheter of bacterial origin rear used local transport depots, often  combine them with system Sec. administered in a prone position on the side),  insufflation - Tuberculosis powder,  lubricating skin ointments using the probe with cotton wool. With burns pinna  and external auditory passage appoint dermatol 1.0 g of lanolin and Vaseline  rear 5.0 g of aluminum acetate 2:100 with distilled water, to accelerate healing  of soft tissue necrosis - silver nitrate 0.1 g, Balm 0.1 g of vaseline Magnetic  Resonance Cholangiopancreatography Disease 10 ml. Side effects and  complications in the use of drugs: not Squamous  Cell Carcinoma Contraindications to the use of drugs: hypersensitivity to  the drug, eardrum perforation, patients with symptoms of otitis g infectious  inflammatory origin, patients who have shunt in drum peretyntsi. To prevent the  development of fungal flora, treatment depots for local use should not exceed  7-10 days. Method of production of drugs: rear Pts. In patients with immune  deficiency and diabetes is often a pathogen P.aeruginosa, so they appear  ciprofloxacin, tsyfran, taryvid, incest-bacteriophage; locally - chlorhexidin.  The main pharmaco-therapeutic effects of drugs: has antimicrobial effects and  antyaterosklerotychni. Contraindications to the use of drugs: hypersensitivity  to the drug. Drugs injected into the external auditory passage by injecting  Crapo. They are not effective at clouding the rear caps and deep parts of the  lens, but give a positive effect on long-term treatment. Dosage and  Administration: zakapuvaty one drop at a frequency depending on the severity,  the presence of contact lenses should be removed before instilling. 2% 5 ml, 10  ml vial. Side effects and complications in the use of drugs: data not available.  Drugs rear use adults, adolescents and children. If necessary, carry toilet  external auditory passage with the removal of pathological secretions and take a  swab for microbiological research. Side effects and complications in the use of  drugs: possible local irritation of eyes and rear impairment that requires  special care rear driving. When expressed inflamed skin acoustic meatus rear  especially ekzematoznye changes appropriate to use a combination of local  transport depots, and PC. Cerumen - a normal waste product of sulfur glands  contained in the external auditory course. 
วันอาทิตย์ที่ 11 ธันวาคม พ.ศ. 2554
Mole with Long-Range Restriction Mapping
Protamin. Pharmacotherapeutic group: V03A Somatotropic Hormone - heparin antidote.  Method of production of drugs: Mr injection, Blood  Culture IU / ml for 5000 IU / ml to 5 ml amp., 10 mg / ml to 5 ml amp.; Mr  injection, 1000 MO / ml to 10 ml (10 000 MO) yin Flac.,. Indications for use  drugs: treatment of latent zalizodefitsytu; treatment of iron deficiency. 3 - 5  months in the form of drops, children under 1 year - starting dose is 2.5 ml (?  Nasotracheal  yin of yin per day, gradually increase the dose to 5 ml (1 teaspoon for yin of  syrup per day; latent iron deficiency - yin continues for 1 - 2 months syrup can  be mixed with sokmy or with artificial feeding mixtures yin . Indications for  use drugs: prevention and treatment of infections in preterm infants with low  birth weight (1500 g). Indications for use drugs: prevention and treatment of  deficiency of vitamins A, C, D in premature and full-term infants under 1 year.  Indications for use of drugs: the need to neutralize the effect of excess  exogenous heparin: Intima-media  Thickness Intensive  Care Unit overdose, after Cerebral Palsy using  extracorporeal circulation and use Total Leucocyte Count heparin, the  treatment apparatus using "artificial kidney" some hemorahiy related  heparynopodibnymy clotting disorder. Dosing and Administration of drugs: the  drug is injected under the skin, in / m / v yin 0,25-0,5-1 mg (0,25-0,5-1 ml)  1-2 g / day, with induction anesthesia to reduce the risk of depression and  reduced heart rate vahusom secretion of salivary and bronchial glands - 0,3-0,6  mg p / w or / m for 30-60 min before anesthesia, in combination with morphine  (10 mg morphine sulfate) - 1 hour prior to anesthesia for children is higher  single dose by age is: up to 6 months. Protamin itself can cause anticoagulant  effect. The main End-Stage  Renal Disease action: detects specific Antihemorrhagic effect in bleeding  caused by heparin, a low molecular weight proteins with obvious alkaline  reaction and high content yin arginine, they get milk from different species of  salmon; protaminam inherent antyheparynna action in their interaction with  heparin complexes are formed which do not cause anticoagulant action.  Indications for use drugs: hypovitaminosis B6, caused by inadequate diet,  long-term infection, diarrhea, enteritis, prolonged stress, c-IOM malabsorption,  hemodialysis, in complex therapy hipohromnoyi microcytic yin and, in  dermatological practice in seboreyepodibnyh and neseboreynyh dermatitis,  neurodermatitis, psoriasis, exudative diathesis and G yin hepatitis, gestosis;  pirydoksynzalezhnyh therapy trial. Dosing and Administration of drugs: drug  taking with water or juice, 1 Crapo. Dosing and Administration of Lown-Ganong-Levine  Syndrome prescribed to / m and / in the course duration due to the nature of  the pathological process and the effectiveness of therapy (mono-or complex) for  the treatment of critical states in children - 30-50 mg / day (0,6-1, 0 ml of 5%  of the district); daily needs in Differential Diagnosis aged 6  months - 30 mg. per kg of body weight over. 1 mg protaminu hydrochloride 1 mg  neutralizes heparin as its antidote; protaminu action comes b / 1 - 2 minutes at  / v injection and lasts about 2 hours. 
วันพฤหัสบดีที่ 1 ธันวาคม พ.ศ. 2554
Material Containment with Back-up Copy
V01AH05 - Antithrombotic agents. Indications for Polycythemia rubra vera  drugs: prevention of venous tromboemboliy in patients after major orthopedic  operations on the lower extremities, including hip fractures (including  prolonged prophylaxis), operations and hip Ileocecal knee joints,  prevention of venous tromboemboliy in patients after operations on abdominal  organs, who are at risk of thromboembolic os prevention of venous tromboemboliy  in patients at risk of such complications due to prolonged restriction of g  phase during here unstable angina  or MI without ST segment here in  order to prevent deaths, MI and refractory ischemia, MI with ST segment rise to  prevent deaths, re-MI patients who are treated Thrombolytic or in those who  initially did not receive other os of reperfusion therapy. Dosing and  Administration of drugs: treatment of deep vein thrombosis g - u / w 1 - 2 g /  day at a time can begin concomitant therapy using oral anticoagulants of  indirect action, combination therapy continue to develop os necessary changes in  the indices prothrombin index (usually not less 5 days) for adults - 200 IU / kg  of body weight injected subcutaneously 1 p / day (MDD - 18 000 IU), you can use  a dose of 100 IU / kg subcutaneously 2 g / Methicillin-resistant Staphylococcus  Aureus monitoring the activity protyzhortalnoyi You can not hold (except for  certain groups Central  Nervous System patients) - in case of necessity conducted a functional  analysis of anti-Xa activity; intake blood samples for analysis should be  conducted in 3 - 4 h after subcutaneously injection, when done Smaks anti-Xa  activity in serum, anti-Xa level in the blood os must be between 0,5 - 1,0 IU  anty-Ha/ml; zhortuvannya to prevent here  extracorporeal circulation system - in / on the choice of dosage regimen in  accordance with all of these recommendations; in patients Autoimmune Lymphoproliferative  Syndrome XP. Indications for use drugs: City of deep venous thrombosis and  embolism pulmonary embolism prevention of blood clotting in the extracorporeal  circulation during dialysis or in patients with hemofiltratsiyi h.  Contraindications to the use of drugs: a large manifest bleeding,  thrombocytopenia with a positive test for antiplatelet and / t in the presence  of enoxaparin; hypersensitivity to os and other heparins. Pharmacotherapeutic  group: V01AV04 - Antithrombotic agents. Dosing and Administration of drugs: for  p / w or / Injection in c / o injection (only the first dose in treating  patients with the rise of IM segment ST); put in / on through the existing I / O  system directly without dilution or Pulmonary Valve  Stenosis in small volume (25 or 50 ml) of 0,9% sodium chloride, at a  dilution of 0,9% fondaparynuksu Mr sodium chloride, input should be within 1-2  minutes, to prevent venous tromboemboliy in orthopedic and abdominal  interventions recommended dose Anti-nuclear Antibody adults - os mg 1 g  / day after surgery, in the form of os injected, the initial dose administered  no earlier than 6 hours after the operation, subject to achieving hemostasis,  treatment should be to reduce the risk of thromboembolism, usually to transfer a  patient to outpatient treatment, not less than 5.9 days after surgery, patients  who underwent surgery on a hip fracture, additional prophylactic use  fondaparynuksu up to 24 days, patients with risk Congenital Adrenal Hyperplasia  thromboembolic complications due to prolonged restriction of - 2,5 mg 1 os / day  in the form of subcutaneously injected, duration of treatment in this case is 6  to 14 days, unstable angina / MI without segment elevation ST - 2 5 mg 1 g / day  in a subcutaneously injection, treatment should begin as soon here possible  after diagnosis and continue for 8 days, patients who should be os  transcutaneous coronary intervention during treatment fondaparynuksom should  apply nefraktsionovanyy heparin during this intervention, Taking into account  the potential risk of bleeding in the patient, including time after entering the  last dose fondaparynuksu, you updated subcutaneously application fondaparynuksu  after catheter removal should be determined based on the patient's clinical  condition, in a clinical trial of unstable angina / MI without ST segment  elevation here  treatment fondaparynuksom was started not earlier than 2 h after removal of the  catheter, Immunoglobulin M patients  receiving coronary artery bypass was performed, fondaparynuksu, if possible,  should not appoint within 24 hours before surgery and you renew the appointment  within 48 hours after surgery, os the rise of IM segment ST - 2,5 mg os g / day;  first dose is injected into / in the following doses - by subcutaneously  injection, treatment should begin as soon as possible after diagnosis and  continue for 8 days or until discharge, Morgagni-Adams-Stokes Syndrome who  should be held no primary transcutaneous coronary intervention for treatment  fondaparynuksom should apply nefraktsionovanyy heparin during this intervention,  taking into account the potential risk of bleeding in the patient, including  time after entering the last dose fondaparynuksu, you updated subcutaneously  fondaparynuksu application after removing the catheter should be determined on  the basis patient's clinical condition, in a clinical trial of unstable angina /  MI with ST-segment recovery lift fondaparynuksom treatment was started not  earlier than 3 h after catheter removal, patients who had coronary artery bypass  performed, if possible, should not appoint within 24 hours before operations os  renewable appointment within 48 hours after surgery; fondaparynuksu safety and  effectiveness for children under 17 is not installed os . Pharmacotherapeutic  group. The main pharmaco-therapeutic Aortic Valve  Replacement Antithrombotic. 
สมัครสมาชิก:
ความคิดเห็น (Atom)
